EMAIL THIS PAGE TO A FRIEND

PloS one

Highly and Broad-Spectrum In Vitro Antitumor Active cis-Dichloridoplatinum(II) Complexes with 7-Azaindoles.


PMID 26309251

Abstract

The cis-[PtCl2(naza)2] complexes (1-3) containing monosubstituted 7-azaindole halogeno-derivatives (naza), showed significantly higher activity than cisplatin towards ovarian carcinoma A2780, its cisplatin-resistant variant A2780R, osteosarcoma HOS, breast carcinoma MCF7 and cervix carcinoma HeLa cell lines, with the IC50 values of 3.8, 3.5, 4.5, 2.7, and 9.2 μM, respectively, obtained for the most active complex 3. As for 4 and 5 having disubstituted 7-azaindoles in their molecule, the significant cytotoxicity was detected only for 4 against A2780 (IC50 = 4.8 μM), A2780R (IC50 = 3.8 μM) and HOS (IC50 = 4.3 μM), while 5 was evaluated as having only moderate antiproliferative effect against the mentioned cancer cell lines with IC50 = 33.4, 24.7 and 46.7 μM, respectively. All the studied complexes 1-5 effectively avoided the acquired resistance of ovarian carcinoma cell line. On the other hand, the complexes did not reveal any inhibition activity on the purified 20S proteasome from the A2780 cells. The representative complexes 3 and 5 showed low ability to be hydrolysed, but their stability was markedly lowered in the presence of physiological sulphur-containing biomolecule glutathione (GSH), as proved by the 1H NMR spectroscopy and mass spectrometry studies. A rate of interaction of the studied complexes with GSH was affected by an addition of another mechanistically relevant biomolecule guanosine monophosphate. The differences in interactions of 3 and 5 with GSH correlate well with their different cytotoxicity profiles.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

694711
3-Bromo-7-azaindole, 97%
C7H5BrN2
703451
4-Bromo-7-azaindole, 96%
C7H5BrN2
696218
4-Chloro-7-azaindole, 97%
C7H5ClN2
702315
5-Bromo-3-chloro-7-azaindole, 96%
C7H4BrClN2
702307
5-Bromo-3-iodo-7-azaindole, 97%
C7H4BrIN2
00561
Acetone, for luminescence, ≥99.5% (GC)
C3H6O
W332607
Acetone, ≥99%, meets FCC analytical specifications
C3H6O
W332615
Acetone, natural, ≥97%
C3H6O
01-0520
Acetone, for HPLC
C3H6O
01-0494
Acetone, for residue analysis, suitable for 5000 per JIS
C3H6O
01-0475
Acetone, suitable for determination of dioxins
C3H6O
686530
Acetone solution, contains 20.0 % (v/v) acetonitrile, for HPLC
C3H6O
479306
cis-Diamineplatinum(II) dichloride, ≥99.9% trace metals basis
H6Cl2N2Pt
P4394
cis-Diammineplatinum(II) dichloride, crystalline
H6Cl2N2Pt
296082
Diethyl ether, contains 1 ppm BHT as inhibitor, anhydrous, ≥99.7%
C4H10O
09-1833
Diethyl ether, for residue analysis, suitable for 5000 per JIS
C4H10O
09-1855
Diethyl ether
C4H10O
G8377
Guanosine 5′-monophosphate disodium salt hydrate, from yeast, ≥99%
C10H12N5Na2O8P · xH2O
87070202
HOS
G4251
L-Glutathione reduced, ≥98.0%
C10H17N3O6S
G6529
L-Glutathione reduced, BioXtra, ≥98.0%
C10H17N3O6S
G6013
L-Glutathione reduced, cell culture tested, BioReagent, ≥98.0%, powder
C10H17N3O6S
S6501
Streptomycin sulfate salt, powder
C21H39N7O12 · 1.5H2O4S
S9137
Streptomycin sulfate salt, powder, BioReagent, suitable for cell culture
C21H39N7O12 · 1.5H2O4S
S1277
Streptomycin sulfate salt, powder, BioXtra, suitable for mouse embryo cell culture
C21H39N7O12 · 1.5H2O4S
P1525
trans-Platinum(II)diammine dichloride
H6Cl2N2Pt